Aptevo Therapeutics APVO Q4 2025 Annual earnings
Reported March 20, 2026 · Before market open
EPS$1,684.47Beat by $1,692.56
EPS estimate-$8.09
Next report
Aug 10, 2026 (In 1 week)EPS estimate-$6.02
Versus estimates
Diluted EPS
Ask the moment Aptevo Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Aptevo Therapeutics report Q4 2025 earnings?
- Aptevo Therapeutics (APVO) reported Q4 2025 earnings on March 20, 2026 before market open.
- What were Aptevo Therapeutics's Q4 2025 revenue and EPS?
- Aptevo Therapeutics reported eps of $1684.47 for Q4 2025.
- Did Aptevo Therapeutics beat estimates in Q4 2025?
- EPS beat the consensus estimate of $-8.09 by $1692.56.
- Where can I find Aptevo Therapeutics's Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001193125-26-126278) directly on SEC EDGAR. The filing index links above go to sec.gov.